Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Food Effect of K0706 Tablet vs Capsule in Healthy Subjects
NCT03316820Phase 1Completed
- Sponsor
- Sun Pharma
- Start
- Oct 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vodobatinib in Parkinson's disease (PD) (4 arms), sponsored by Sun Pharma. Primary endpoint: Observed peak plasma concentration at 72 hours. Started Oct 2017; status: completed.
02
Drugs
vodobatinib
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03316820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03316820.